Clinical Trials List
Protocol Number96WFA0901063
Not yet recruiting
2008-08-01 - 2011-07-31
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 姚維仁 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
135 participants
-
Global
0 participants
